DJIA 16,472.37 200.36 1.23%
NASDAQ 4,707.78 80.69 1.74%
S&P 500 1,951.36 27.54 1.43%
market minute promo


142.47 2.24 (1.60%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $142.47 1.60%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $138.26
Previous Close $140.23
Daily Range $135.64 - $142.54
52-Week Range $127.67 - $181.81
Market Cap $108.0B
P/E Ratio 18.57
Dividend (Yield) $3.16 (2.3%)
Ex-Dividend Date
Dividend Pay Date
Volume 4,800,546
Average Daily Volume 4,621,412
Current FY EPS $9.73




Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary Rss Feed

Amgen Is In Novartis' Crosshair

After winning approval for a biosimilar to Amgen's Neupogen, Novartis has filed for approval of another biosimilar. This time its target is Amgen's Enbrel.

Health Care Sector Update for 10/02/2015: CHRS,AMGN,XNPT,FOLD

US Stock Futures Up; All Eyes On Jobs Report

Biotech Stock Mailbag: Akebia, Neuralstem, Arrowhead

FDA Accepts Novartis/Sandoz Regulatory Submission for Proposed Biosimilar to Enbrel

Activist Investing Daily: Still Value In Real Estate

Stock Market News for October 01, 2015

Pfizer Raises 2015 Outlook on Hospira Acquisition, Shares Up

Can You Guess Which Surprising Company Is Trying to Become a Cardiovascular Drug Giant?

From $0 in cardiovascular sales last year to multiple billions of dollars in sales by 2020? This biotech behemoth just might be able to do it.

Are These 5 Popular Dividend Stocks Truly Cheap?

See More AMGN News...

AMGN's Top Competitors

AMGN $142.47 (1.60%)
Current stock: AMGN
GILD $98.28 (0.01%)
Current stock: GILD
CELG $116.39 (3.13%)
Current stock: CELG
$0.00 (0.00%)
Current stock: